Bayer Second-Quarter Profit Gains 5.7% Amid Monsanto PursuitBy
German company trims its revenue forecast for this year
Crop sciences sales to be flat in “weak market environment”
Bayer AG, the German chemicals company seeking to acquire Monsanto Co., reported a 5.7 percent increase in second-quarter profit as prescription-drug sales helped offset weakness in its crop sciences and consumer health units.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.